Literature DB >> 27539837

2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET.

Ka Kit Wong1,2, David M Raffel3, Nicolaas I Bohnen3,2,4,5, Gulcin Altinok3, Sid Gilman6, Kirk A Frey3,7.   

Abstract

The objective of this study was to detect regional patterns of cardiac sympathetic denervation in idiopathic Parkinson disease (IPD) using 11C-hydroxyephedrine (11C-HED) PET and determine the denervation rate over 2 y.
METHODS: We obtained 62 cardiac 11C-HED PET scans in 39 patients (30 men and 9 women; mean age ± SD, 61.9 ± 5.9 y), including 23 patients with follow-up scans at 2 y. We derived 11C-HED retention indices (RIs; mL of blood/min/mL of tissue) reflecting nerve density and integrity for 480 left ventricular (LV) sectors. We compared IPD patients with 33 healthy controls using z score analysis; RI values ≤ 2.5 SDs were considered abnormal. We expressed global and regional LV denervation as the percentage extent of z score severity and severity-extent product (SEP) on 9-segment bullseye maps and decline in cardiac sympathetic innervation as the 2-y difference in SEP (diff-SEP).
RESULTS: Baseline 11C-HED PET in the 39 IPD patients revealed an RI mean of 0.052 ± 0.022 mL of blood/min/mL of tissue. In comparison with data from normal controls, 12 patients had normal 11C-HED PET, 5 showed mild denervation (percentage extent < 30%), and 22 had moderate to severe denervation (percentage extent > 30%, z score ≤ 2.5 SD). In the 23 paired PET scans, worsening cardiac denervation (global diff-SEP > 9) occurred in 14 of 23 (60.9%) patients over 2 y, including percentage LV abnormality (59% increasing to 66%), z-severity (-2.4 down to -2.5), and SEP (-195 to -227) (P = 0.0062). We found a mean annual decline of 4.6% ± 5.6 (maximum, 13%) in 11C-HED retention from a baseline global RI mean of 0.0481 ± 0.0218 to 0.0432 ± 0.0220 (P = 0.0009). At baseline, 5 patients with normal uptake had no interval change; 3 with mild denervation developed interval decline in lateral and inferior segments (diff-SEP -82 to -99) compared with anterior and septal segments (-65 to -79), whereas the reverse pattern occurred in 15 patients with severe baseline denervation.
CONCLUSION: Progressive decline in cardiac sympathetic neural integrity in IPD patients occurs at a modest rate over 2 y on 11C-HED scans with marked heterogeneity and a regional pattern of involvement and decline.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  11C-hydroxyephedrine PET; Parkinson disease; autonomic nervous system; cardiac sympathetic denervation

Mesh:

Substances:

Year:  2016        PMID: 27539837      PMCID: PMC5288743          DOI: 10.2967/jnumed.116.176891

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

Review 1.  PET and SPET tracers for mapping the cardiac nervous system.

Authors:  Oliver Langer; Christer Halldin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03       Impact factor: 9.236

2.  Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.

Authors:  Satoshi Orimo; Takeshi Amino; Yoshinori Itoh; Atsushi Takahashi; Tohru Kojo; Toshiki Uchihara; Kuniaki Tsuchiya; Fumiaki Mori; Koichi Wakabayashi; Hitoshi Takahashi
Journal:  Acta Neuropathol       Date:  2005-06-03       Impact factor: 17.088

Review 3.  EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

Authors:  A Berardelli; G K Wenning; A Antonini; D Berg; B R Bloem; V Bonifati; D Brooks; D J Burn; C Colosimo; A Fanciulli; J Ferreira; T Gasser; F Grandas; P Kanovsky; V Kostic; J Kulisevsky; W Oertel; W Poewe; J-P Reese; M Relja; E Ruzicka; A Schrag; K Seppi; P Taba; M Vidailhet
Journal:  Eur J Neurol       Date:  2013-01       Impact factor: 6.089

Review 4.  Synuclein deposition and non-motor symptoms in Parkinson disease.

Authors:  Kurt A Jellinger
Journal:  J Neurol Sci       Date:  2011-05-12       Impact factor: 3.181

Review 5.  MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.

Authors:  Ryuji Sakakibara; Fuyuki Tateno; Masahiko Kishi; Yohei Tsuyusaki; Hitoshi Terada; Tsutomu Inaoka
Journal:  Parkinsonism Relat Disord       Date:  2013-11-21       Impact factor: 4.891

6.  Cardiac sympathetic denervation in Parkinson disease.

Authors:  D S Goldstein; C Holmes; S T Li; S Bruce; L V Metman; R O Cannon
Journal:  Ann Intern Med       Date:  2000-09-05       Impact factor: 25.391

Review 7.  Scintigraphic evaluation of cardiac autonomic innervation.

Authors:  G Münch; S Ziegler; N Nguyen; F Hartmann; P Watzlowik; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1996 May-Jun       Impact factor: 5.952

8.  Functional and anatomical variability of canine cardiac sympathetic efferent pathways: implications for regional denervation of the left ventricle.

Authors:  R D Janes; D E Johnstone; J C Brandys; J A Armour
Journal:  Can J Physiol Pharmacol       Date:  1986-07       Impact factor: 2.273

9.  Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET.

Authors:  Ka Kit Wong; David M Raffel; Robert A Koeppe; Kirk A Frey; Nicolaas I Bohnen; Sid Gilman
Journal:  Radiology       Date:  2012-07-27       Impact factor: 11.105

10.  Anatomy of human extrinsic cardiac nerves and ganglia.

Authors:  R D Janes; J C Brandys; D A Hopkins; D E Johnstone; D A Murphy; J A Armour
Journal:  Am J Cardiol       Date:  1986-02-01       Impact factor: 2.778

View more
  12 in total

Review 1.  Imaging the Autonomic Nervous System in Parkinson's Disease.

Authors:  Karoline Knudsen; Per Borghammer
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-19       Impact factor: 5.081

2.  Post mortem evaluation of inflammation, oxidative stress, and PPARγ activation in a nonhuman primate model of cardiac sympathetic neurodegeneration.

Authors:  Jeanette M Metzger; Helen N Matsoff; Alexandra D Zinnen; Rachel A Fleddermann; Viktoriya Bondarenko; Heather A Simmons; Andres Mejia; Colleen F Moore; Marina E Emborg
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

Review 3.  The role of neuroimaging in Parkinson's disease.

Authors:  Natasha S R Bidesi; Ida Vang Andersen; Albert D Windhorst; Vladimir Shalgunov; Matthias M Herth
Journal:  J Neurochem       Date:  2021-10-03       Impact factor: 5.546

4.  Long-term trends in myocardial sympathetic innervation and function in synucleinopathies.

Authors:  Guillaume Lamotte; Courtney Holmes; Tianxia Wu; David S Goldstein
Journal:  Parkinsonism Relat Disord       Date:  2019-09-16       Impact factor: 4.891

5.  Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients.

Authors:  Harish Goyal; Anshul Sharma; Chetan Patel; K K Deepak; Madhavi Tripathi; Priyanka Gupta; Rajeev Kumar; Chandra Shekhar Bal; Vinay Goyal
Journal:  J Nucl Cardiol       Date:  2021-01-10       Impact factor: 3.872

6.  Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: Feasibility study in IPD patients.

Authors:  Pamela K Woodard
Journal:  J Nucl Cardiol       Date:  2021-03-09       Impact factor: 3.872

7.  Imaging Parkinson's disease below the neck.

Authors:  Per Borghammer; Karoline Knudsen; Tatyana D Fedorova; David J Brooks
Journal:  NPJ Parkinsons Dis       Date:  2017-04-25

Review 8.  The class II histone deacetylases as therapeutic targets for Parkinson's disease.

Authors:  Martina Mazzocchi; Louise M Collins; Aideen M Sullivan; Gerard W O'Keeffe
Journal:  Neuronal Signal       Date:  2020-06-09

9.  Initial Evaluation of AF78: a Rationally Designed Fluorine-18-Labelled PET Radiotracer Targeting Norepinephrine Transporter.

Authors:  Xinyu Chen; Alexander Fritz; Rudolf A Werner; Naoko Nose; Yusuke Yagi; Hiroyuki Kimura; Steven P Rowe; Kazuhiro Koshino; Michael Decker; Takahiro Higuchi
Journal:  Mol Imaging Biol       Date:  2020-06       Impact factor: 3.488

10.  Propolis as A Potential Disease-Modifying Strategy in Parkinson's Disease: Cardioprotective and Neuroprotective Effects in the 6-OHDA Rat Model.

Authors:  Valeria C Gonçalves; Daniel J L L Pinheiro; Tomás de la Rosa; Antônio-Carlos G de Almeida; Fúlvio A Scorza; Carla A Scorza
Journal:  Nutrients       Date:  2020-05-26       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.